TreeWAS – Variant ID: rs2076756

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K50.9 Crohn's disease, unspecified	1.000	0.000	0.000
K50 Crohn's disease [regional enteritis]	1.000	0.000	0.000
K50.0 Crohn's disease of small intestine	1.000	0.000	0.000
K50.1 Crohn's disease of large intestine	0.992	0.008	0.000
K50.8 Other Crohn's disease	0.982	0.018	0.000
K50-K52 Noninfective enteritis and colitis	0.166	0.834	0.000
F40.2 Specific (isolated) phobias	0.000	0.864	0.136
K51 Ulcerative colitis	0.115	0.885	0.000
K51.8 Other ulcerative colitis	0.108	0.892	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.105	0.895	0.000
K51.5 Mucosal proctocolitis	0.097	0.903	0.000
F40 Phobic anxiety disorders	0.000	0.904	0.096
K51.1 Ulcerative (chronic) ileocolitis	0.090	0.910	0.000
F40.9 Phobic anxiety disorder, unspecified	0.000	0.924	0.076
F40.0 Agoraphobia	0.000	0.928	0.072
F40.8 Other phobic anxiety disorders	0.000	0.931	0.069
F40.1 Social phobias	0.000	0.931	0.069
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.000	0.944	0.056
F40-F48 Neurotic, stress-related and somatoform disorders	0.000	0.946	0.054
K51.4 Pseudopolyposis of colon	0.053	0.947	0.000
F41 Other anxiety disorders	0.000	0.947	0.053
K51.3 Ulcerative (chronic) rectosigmoiditis	0.046	0.954	0.000
F41.8 Other specified anxiety disorders	0.000	0.956	0.044
F41.2 Mixed anxiety and depressive disorder	0.000	0.957	0.043
F48 Other neurotic disorders	0.000	0.959	0.041
F43 Reaction to severe stress, and adjustment disorders	0.000	0.960	0.040
F43.1 Posttraumatic stress disorder	0.000	0.963	0.036
F43.0 Acute stress reaction	0.000	0.965	0.035
F41.3 Other mixed anxiety disorders	0.000	0.966	0.034
F41.1 Generalised anxiety disorder	0.000	0.966	0.034
F44 Dissociative [conversion] disorders	0.000	0.968	0.031
F48.0 Neurasthenia	0.000	0.969	0.031
F48.9 Neurotic disorder, unspecified	0.000	0.971	0.029
F48.8 Other specified neurotic disorders	0.000	0.971	0.029
F48.1 Depersonalisation-derealisation syndrome	0.000	0.971	0.029
F43.8 Other reactions to severe stress	0.000	0.971	0.029
F42 Obsessive-compulsive disorder	0.001	0.972	0.027
F44.5 Dissociative convulsions	0.000	0.976	0.024
F44.7 Mixed dissociative [conversion] disorders	0.000	0.977	0.023
F44.6 Dissociative anaesthesia and sensory loss	0.000	0.977	0.023
F44.3 Trance and possession disorders	0.000	0.977	0.023
F44.2 Dissociative stupor	0.000	0.977	0.023
F44.1 Dissociative fugue	0.000	0.977	0.023
F44.0 Dissociative amnesia	0.000	0.977	0.023
F44.9 Dissociative [conversion] disorder, unspecified	0.000	0.978	0.021
F42.0 Predominantly obsessional thoughts or ruminations	0.001	0.979	0.021
F44.8 Other dissociative [conversion] disorders	0.000	0.979	0.020
F42.8 Other obsessive-compulsive disorders	0.001	0.979	0.020
F42.2 Mixed obsessional thoughts and acts	0.001	0.979	0.020
F42.1 Predominantly compulsive acts [obsessional rituals]	0.001	0.979	0.020
F45 Somatoform disorders	0.000	0.980	0.019
F43.9 Reaction to severe stress, unspecified	0.000	0.981	0.019
K51.2 Ulcerative (chronic) proctitis	0.019	0.981	0.000
K51.9 Ulcerative colitis, unspecified	0.019	0.981	0.000
Y52 Agents primarily affecting the cardiovascular system	0.000	0.981	0.019
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.981	0.019
F44.4 Dissociative motor disorders	0.000	0.982	0.018
Y52.1 Calcium-channel blockers	0.000	0.982	0.018
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.982	0.018
Z39.0 Care and examination immediately after delivery	0.000	0.983	0.017
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.984	0.016
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.984	0.016
F45.4 Persistent somatoform pain disorder	0.000	0.986	0.014
F45.1 Undifferentiated somatoform disorder	0.000	0.986	0.014
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.986	0.014
F45.9 Somatoform disorder, unspecified	0.000	0.986	0.014
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.986	0.014
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.986	0.014
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.986	0.014
F45.0 Somatisation disorder	0.000	0.986	0.013
Y52.7 Peripheral vasodilators	0.000	0.987	0.013
Z39 Postpartum care and examination	0.000	0.987	0.013
Z39.2 Routine postpartum follow-up	0.000	0.988	0.012
F43.2 Adjustment disorders	0.000	0.988	0.012
K52 Other non-infective gastro-enteritis and colitis	0.012	0.988	0.000
F45.2 Hypochondriacal disorder	0.000	0.988	0.012
F45.8 Other somatoform disorders	0.000	0.989	0.011
F41.9 Anxiety disorder, unspecified	0.000	0.989	0.011
F45.3 Somatoform autonomic dysfunction	0.000	0.990	0.009
Z39.1 Care and examination of lactating mother	0.000	0.991	0.009
K52.2 Allergic and dietetic gastro-enteritis and colitis	0.009	0.991	0.000
F42.9 Obsessive-compulsive disorder, unspecified	0.003	0.992	0.005
K52.3 Indeterminate colitis	0.008	0.992	0.000
Y54.3 Benzothiadiazine derivatives	0.000	0.993	0.007
H50.5 Heterophoria	0.007	0.993	0.000
H50.0 Convergent concomitant strabismus	0.007	0.993	0.000
H50 Other strabismus	0.007	0.993	0.000
K52.0 Gastro-enteritis and colitis due to radiation	0.007	0.993	0.000
K52.1 Toxic gastro-enteritis and colitis	0.007	0.993	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.993	0.007
H50.2 Vertical strabismus	0.006	0.994	0.000
Z50.5 Speech therapy	0.000	0.994	0.006
G63.2 Diabetic polyneuropathy	0.000	0.994	0.006
Y40.9 Systemic antibiotic, unspecified	0.000	0.994	0.006
H50.1 Divergent concomitant strabismus	0.006	0.994	0.000
N02.9 Unspecified	0.006	0.994	0.000
H50.8 Other specified strabismus	0.005	0.994	0.000
K66.1 Haemoperitoneum	0.005	0.995	0.000
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.000	0.995	0.005
H50.6 Mechanical strabismus	0.005	0.995	0.000
H50.3 Intermittent heterotropia	0.005	0.995	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.995	0.005
H50.4 Other and unspecified heterotropia	0.005	0.995	0.000
M25.55 Pain in joint (Pelvic region and thigh)	0.000	0.995	0.005
K66 Other disorders of peritoneum	0.005	0.995	0.000
K66.9 Disorder of peritoneum, unspecified	0.005	0.995	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.995	0.005
H50.9 Strabismus, unspecified	0.005	0.995	0.000
J84.8 Other specified interstitial pulmonary diseases	0.000	0.995	0.005
Y41 Other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
C55 Malignant neoplasm of uterus, part unspecified	0.004	0.996	0.000
K66.0 Peritoneal adhesions	0.004	0.996	0.000
J94.2 Haemothorax	0.000	0.996	0.004
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.000	0.996	0.004
J84 Other interstitial pulmonary diseases	0.000	0.996	0.004
Q89.2 Congenital malformations of other endocrine glands	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.000	0.996	0.004
Y54.8 Agents affecting uric acid metabolism	0.000	0.996	0.004
Y54.9 Mineral salts, not elsewhere classified	0.000	0.996	0.004
Y54.7 Agents affecting calcification	0.000	0.996	0.004
Y54.6 Electrolytic, caloric and water-balance agents	0.000	0.996	0.004
Y54.2 Carbonic-anhydrase inhibitors	0.000	0.996	0.004
Y54.4 Loop [high-ceiling] diuretics	0.000	0.996	0.004
J39.8 Other specified diseases of upper respiratory tract	0.000	0.996	0.004
Y40 Systemic antibiotics	0.000	0.996	0.004
S40.0 Contusion of shoulder and upper arm	0.000	0.996	0.004
T78.4 Allergy, unspecified	0.004	0.996	0.000
Y41.5 Antiviral drugs	0.000	0.996	0.004
Y48 Anaesthetics and therapeutic gases	0.000	0.996	0.004
E16.2 Hypoglycaemia, unspecified	0.004	0.996	0.000
Y41.0 Sulphonamides	0.000	0.996	0.003
H52.2 Astigmatism	0.000	0.997	0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
Y41.4 Anthelminthics	0.000	0.997	0.003
Y41.3 Other antiprotozoal drugs	0.000	0.997	0.003
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
S62.30 Fracture of other metacarpal bone (closed)	0.000	0.997	0.003
M80.9 Unspecified osteoporosis with pathological fracture	0.000	0.997	0.003
Y54.0 Mineralocorticoids	0.000	0.997	0.003
Y41.1 Antimycobacterial drugs	0.000	0.997	0.003
E11.5 With peripheral circulatory complications	0.000	0.997	0.003
J84.0 Alveolar and parietoalveolar conditions	0.000	0.997	0.003
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.003	0.997	0.000
T93.9 Sequelae of unspecified injury of lower limb	0.003	0.997	0.000
Y54.5 Other diuretics	0.000	0.997	0.003
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.003	0.997	0.000
N18.4 Chronic kidney disease, stage 4	0.000	0.997	0.003
Y48.3 Local anaesthetics	0.000	0.997	0.003
Z93.3 Colostomy status	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.000	0.997	0.003
Y58 Bacterial vaccines	0.000	0.997	0.003
Y50 Central nervous system stimulants, not elsewhere classified	0.000	0.997	0.003
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)	0.000	0.997	0.003
K66.8 Other specified disorders of peritoneum	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
K65.0 Acute peritonitis	0.003	0.997	0.000
T93.2 Sequelae of other fractures of lower limb	0.003	0.997	0.000
R82 Other abnormal findings in urine	0.003	0.997	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.003	0.997	0.000
Y40.0 Penicillins	0.000	0.997	0.003
Y48.2 Other and unspecified general anaesthetics	0.000	0.997	0.003
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
Y40.7 Antifungal antibiotics, systemically used	0.000	0.997	0.003
Y40.6 Rifamycins	0.000	0.997	0.003
Y40.4 Tetracyclines	0.000	0.997	0.003
Y40.2 Chloramphenicol group	0.000	0.997	0.003
R82.7 Abnormal findings on microbiological examination of urine	0.003	0.997	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.003	0.997	0.000
G63 Polyneuropathy in diseases classified elsewhere	0.000	0.997	0.003
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.000	0.997	0.003
Y48.1 Parenteral anaesthetics	0.000	0.997	0.003
Y48.0 Inhaled anaesthetics	0.000	0.997	0.003
K65-K67 Diseases of peritoneum	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.000	0.997	0.003
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.003	0.997	0.000
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.000	0.997	0.003
T93 Sequelae of injuries of lower limb	0.003	0.997	0.000
R82.4 Acetonuria	0.003	0.997	0.000
W44.0 Home	0.000	0.997	0.003
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.000	0.997	0.003
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.000	0.997	0.003
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.000	0.997	0.003
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.000	0.997	0.003
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.000	0.997	0.003
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.000	0.997	0.003
R82.1 Myoglobinuria	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
O72.1 Other immediate postpartum haemorrhage	0.000	0.997	0.003
R82.9 Other and unspecified abnormal finding in urine	0.003	0.997	0.000
D23.6 Skin of upper limb, including shoulder	0.000	0.997	0.003
Y53.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
Y57 Other and unspecified drugs and medicaments	0.000	0.997	0.003
Y47 Sedatives, hypnotics and antianxiety drugs	0.000	0.997	0.002
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.000	0.997	0.003
K63.3 Ulcer of intestine	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.000	0.997	0.002
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.997	0.003
Y40.3 Macrolides	0.000	0.997	0.003
K65 Peritonitis	0.003	0.997	0.000
Y58.0 BCG vaccine	0.000	0.997	0.002
J94 Other pleural conditions	0.000	0.997	0.003
Y45.0 Opioids and related analgesics	0.000	0.997	0.003
Q89 Other congenital malformations, not elsewhere classified	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.000	0.997	0.002
Y59.8 Other specified vaccines and biological substances	0.000	0.997	0.002
Y59.2 Protozoal vaccines	0.000	0.997	0.002
Y59.1 Rickettsial vaccines	0.000	0.997	0.002
Y59.0 Viral vaccines	0.000	0.997	0.002
Y58.9 Other and unspecified bacterial vaccines	0.000	0.997	0.002
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.000	0.997	0.002
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.000	0.997	0.002
Y58.5 Diphtheria vaccine	0.000	0.997	0.002
Y58.4 Tetanus vaccine	0.000	0.997	0.002
Y58.3 Plague vaccine	0.000	0.997	0.002
Y58.2 Cholera vaccine	0.000	0.997	0.002
Y58.1 Typhoid and paratyphoid vaccine	0.000	0.997	0.002
Y50.9 Central nervous system stimulant, unspecified	0.000	0.997	0.002
Y50.8 Other central nervous system stimulants	0.000	0.997	0.002
Y50.2 Methylxanthines, not elsewhere classified	0.000	0.997	0.002
Y50.1 Opioid receptor antagonists	0.000	0.997	0.002
Y50.0 Analeptics	0.000	0.997	0.002
T93.8 Sequelae of other specified injuries of lower limb	0.003	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.000	0.997	0.003
S27.1 Traumatic haemothorax	0.000	0.997	0.002
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.002
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.002
Y53.7 Emetics	0.000	0.997	0.002
Y53.6 Antidiarrhoeal drugs	0.000	0.997	0.002
Y53.5 Digestants	0.000	0.997	0.002
Y53.3 Saline and osmotic laxatives	0.000	0.997	0.002
Y53.2 Stimulant laxatives	0.000	0.997	0.002
Y53.0 Histamine H2-receptor antagonists	0.000	0.997	0.002
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R82.3 Haemoglobinuria	0.002	0.998	0.000
R82.2 Biliuria	0.002	0.998	0.000
R82.0 Chyluria	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.000	0.998	0.002
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.002
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
Y55.5 Anticommon cold drugs	0.000	0.998	0.002
Y55.4 Expectorants	0.000	0.998	0.002
Y55.3 Antitussives	0.000	0.998	0.002
Y55.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
Y55.0 Oxytocic drugs	0.000	0.998	0.002
Y46 Antiepileptics and anti-Parkinsonism drugs	0.000	0.998	0.002
S82.10 Fracture of upper end of tibia (closed)	0.002	0.998	0.000
G63.8 Polyneuropathy in other diseases classified elsewhere	0.000	0.998	0.002
G63.6 Polyneuropathy in other musculoskeletal disorders	0.000	0.998	0.002
G63.5 Polyneuropathy in systemic connective tissue disorders	0.000	0.998	0.002
G63.4 Polyneuropathy in nutritional deficiency	0.000	0.998	0.002
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.000	0.998	0.002
G63.1 Polyneuropathy in neoplastic disease	0.000	0.998	0.002
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.000	0.998	0.002
M35.3 Polymyalgia rheumatica	0.000	0.998	0.002
K67 Disorders of peritoneum in infectious diseases classified elsewhere	0.002	0.998	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.998	0.002
T78.1 Other adverse food reactions, not elsewhere classified	0.002	0.998	0.000
F06.7 Mild cognitive disorder	0.002	0.998	0.000
S27.0 Traumatic pneumothorax	0.000	0.998	0.002
T78 Adverse effects, not elsewhere classified	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.000	0.998	0.002
Y40.5 Aminoglycosides	0.000	0.998	0.002
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.002	0.998	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.002	0.998	0.000
E23.2 Diabetes insipidus	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.000	0.998	0.002
Y49.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
Y49.7 Psychostimulants with abuse potential	0.000	0.998	0.002
Y49.6 Psychodysleptics [hallucinogens]	0.000	0.998	0.002
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
N02 Recurrent and persistent haematuria	0.002	0.998	0.000
J94.8 Other specified pleural conditions	0.000	0.998	0.002
T93.1 Sequelae of fracture of femur	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.000	0.998	0.002
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.000	0.998	0.002
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.000	0.998	0.002
Y47.4 Bromine compounds	0.000	0.998	0.002
Y47.3 Paraldehyde	0.000	0.998	0.002
Y47.2 Chloral derivatives	0.000	0.998	0.002
Y47.0 Barbiturates, not elsewhere classified	0.000	0.998	0.002
K75.0 Abscess of liver	0.000	0.998	0.002
Y55.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
Y57.9 Drug or medicament, unspecified	0.000	0.998	0.002
Y57.7 Vitamins, not elsewhere classified	0.000	0.998	0.002
Y57.4 Pharmaceutical excipients	0.000	0.998	0.002
Y57.3 Alcohol deterrents	0.000	0.998	0.002
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
Y57.1 Lipotropic drugs	0.000	0.998	0.002
Y57.0 Appetite depressants [anorectics]	0.000	0.998	0.002
M80 Osteoporosis with pathological fracture	0.000	0.998	0.002
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.002	0.998	0.000
T93.0 Sequelae of open wound of lower limb	0.002	0.998	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.002	0.998	0.000
J94.9 Pleural condition, unspecified	0.000	0.998	0.002
J94.0 Chylous effusion	0.000	0.998	0.002
N02.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
Q89.9 Congenital malformation, unspecified	0.002	0.998	0.000
Q89.8 Other specified congenital malformations	0.002	0.998	0.000
Q89.7 Multiple congenital malformations, not elsewhere classified	0.002	0.998	0.000
Q89.4 Conjoined twins	0.002	0.998	0.000
Q89.3 Situs inversus	0.002	0.998	0.000
Q89.1 Congenital malformations of adrenal gland	0.002	0.998	0.000
Q89.0 Congenital malformations of spleen	0.002	0.998	0.000
S42.40 Fracture of lower end of humerus (closed)	0.002	0.998	0.000
K91.4 Colostomy and enterostomy malfunction	0.002	0.998	0.000
Y53.4 Other laxatives	0.000	0.998	0.002
Y51 Drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
J94.1 Fibrothorax	0.000	0.998	0.002
Y45.1 Salicylates	0.000	0.998	0.002
Y43 Primarily systemic agents	0.000	0.998	0.002
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.998	0.002
Y45.4 Antirheumatics	0.000	0.998	0.002
E16 Other disorders of pancreatic internal secretion	0.002	0.998	0.000
S27.11 Traumatic haemothorax (with open wound into thoracic cavity)	0.000	0.998	0.002
K75.9 Inflammatory liver disease, unspecified	0.000	0.998	0.002
Y49.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
Y57.6 Other diagnostic agents	0.000	0.998	0.002
T78.0 Anaphylactic shock due to adverse food reaction	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.000	0.998	0.002
S27 Injury of other and unspecified intrathoracic organs	0.000	0.998	0.002
K91.0 Vomiting following gastro-intestinal surgery	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.000	0.998	0.002
K52.8 Other specified non-infective gastro-enteritis and colitis	0.002	0.998	0.000
O72.0 Third-stage haemorrhage	0.000	0.998	0.002
T78.2 Anaphylactic shock, unspecified	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.000	0.998	0.002
Y46.7 Anti-Parkinsonism drugs	0.000	0.998	0.002
Y46.5 Valproic acid	0.000	0.998	0.002
Y46.3 Deoxybarbiturates	0.000	0.998	0.002
Y46.1 Oxazolidinediones	0.000	0.998	0.002
Y46.0 Succinimides	0.000	0.998	0.002
Y57.5 X-ray contrast media	0.000	0.998	0.002
M80.5 Idiopathic osteoporosis with pathological fracture	0.000	0.998	0.002
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.998	0.002
Y57.8 Other drugs and medicaments	0.000	0.998	0.002
H51 Other disorders of binocular movement	0.002	0.998	0.000
M80.0 Postmenopausal osteoporosis with pathological fracture	0.000	0.998	0.002
E16.1 Other hypoglycaemia	0.002	0.998	0.000
K67.8 Other disorders of peritoneum in infectious diseases classified elsewhere	0.002	0.998	0.000
K67.3 Tuberculous peritonitis	0.002	0.998	0.000
K67.2 Syphilitic peritonitis	0.002	0.998	0.000
K67.1 Gonococcal peritonitis	0.002	0.998	0.000
K67.0 Chlamydial peritonitis	0.002	0.998	0.000
M80.1 Postoophorectomy osteoporosis with pathological fracture	0.000	0.998	0.002
H49 Paralytic strabismus	0.002	0.998	0.000
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.000	0.998	0.002
I85.9 Oesophageal varices without bleeding	0.000	0.998	0.002
S69.9 Unspecified injury of wrist and hand	0.002	0.998	0.000
T78.9 Adverse effect, unspecified	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.000	0.998	0.002
Y56.8 Other topical agents	0.000	0.998	0.002
Y56.7 Dental drugs, topically applied	0.000	0.998	0.002
Y56.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
Y56.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
Y56.2 Local astringents and local detergents	0.000	0.998	0.002
Y56.1 Antipruritics	0.000	0.998	0.002
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.000	0.998	0.002
M80.8 Other osteoporosis with pathological fracture	0.000	0.998	0.002
M41.99 Scoliosis, unspecified (Site unspecified)	0.002	0.998	0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.002	0.998	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N02.6 Dense deposit disease	0.002	0.998	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N02.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N02.0 Minor glomerular abnormality	0.002	0.998	0.000
M80.50 Idiopathic osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.002
K65.8 Other peritonitis	0.002	0.998	0.000
M80.4 Drug-induced osteoporosis with pathological fracture	0.000	0.998	0.002
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture	0.000	0.998	0.002
M80.2 Osteoporosis of disuse with pathological fracture	0.000	0.998	0.002
H49.2 Sixth [abducent] nerve palsy	0.002	0.998	0.000
S27.2 Traumatic heamopneumothorax	0.000	0.998	0.002
Y56.3 Emollients, demulcents and protectants	0.000	0.998	0.002
M80.88 Other osteoporosis with pathological fracture (Other)	0.000	0.998	0.002
S62.3 Fracture of other metacarpal bone	0.000	0.998	0.002
Y40.8 Other systemic antibiotics	0.000	0.998	0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
Y51.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
Y51.0 Anticholinesterase agents	0.000	0.998	0.002
H51.2 Internuclear ophthalmoplegia	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.000	0.998	0.002
Y43.8 Other primarily systemic agents, not elsewhere classified	0.000	0.998	0.002
Y43.6 Enzymes, not elsewhere classified	0.000	0.998	0.002
Y43.5 Acidifying and alkalising agents	0.000	0.998	0.002
Y43.4 Immunosuppressive agents	0.000	0.998	0.002
Y43.2 Antineoplastic natural products	0.000	0.998	0.002
Y43.1 Antineoplastic antimetabolites	0.000	0.998	0.002
Y46.4 Iminostilbenes	0.000	0.998	0.002
E16.9 Disorder of pancreatic internal secretion, unspecified	0.002	0.998	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.002	0.998	0.000
E16.4 Abnormal secretion of gastrin	0.002	0.998	0.000
E16.3 Increased secretion of glucagon	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.000	0.998	0.002
Y46.2 Hydantoin derivatives	0.000	0.998	0.002
Y47.1 Benzodiazepines	0.001	0.998	0.001
Y49.5 Other antipsychotics and neuroleptics	0.000	0.998	0.001
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.000	0.998	0.002
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.002
C71.9 Brain, unspecified	0.002	0.998	0.000
T78.8 Other adverse effects, not elsewhere classified	0.002	0.998	0.000
M25.59 Pain in joint (Site unspecified)	0.000	0.998	0.002
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.002
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.000	0.998	0.002
H49.0 Third [oculomotor] nerve palsy	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.998	0.001
Y44.7 Plasma substitutes	0.000	0.998	0.001
Y44.6 Natural blood and blood products	0.000	0.998	0.001
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.998	0.001
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.998	0.001
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
S27.9 Injury of unspecified intrathoracic organ	0.000	0.998	0.002
S27.8 Injury of other specified intrathoracic organs	0.000	0.998	0.002
S27.7 Multiple injuries of intrathoracic organs	0.000	0.998	0.002
S27.6 Injury of pleura	0.000	0.998	0.002
S27.5 Injury of thoracic trachea	0.000	0.998	0.002
S27.4 Injury of bronchus	0.000	0.998	0.002
Y43.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.001
S62.31 Fracture of other metacarpal bone (open)	0.000	0.998	0.002
H49.9 Paralytic strabismus, unspecified	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
Y46.6 Other and unspecified antiepileptics	0.000	0.998	0.001
M80.59 Idiopathic osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.002
M80.58 Idiopathic osteoporosis with pathological fracture (Other)	0.000	0.998	0.002
M80.57 Idiopathic osteoporosis with pathological fracture (Ankle and foot)	0.000	0.998	0.002
M80.56 Idiopathic osteoporosis with pathological fracture (Lower leg)	0.000	0.998	0.002
M80.55 Idiopathic osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.002
M80.54 Idiopathic osteoporosis with pathological fracture (Hand)	0.000	0.998	0.002
M80.53 Idiopathic osteoporosis with pathological fracture (Forearm)	0.000	0.998	0.002
M80.51 Idiopathic osteoporosis with pathological fracture (Shoulder region)	0.000	0.998	0.002
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.002	0.998	0.000
K91.1 Postgastric surgery syndromes	0.002	0.998	0.000
S27.3 Other injuries of lung	0.000	0.998	0.002
M80.09 Postmenopausal osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.001
M80.08 Postmenopausal osteoporosis with pathological fracture (Other)	0.000	0.998	0.001
M80.07 Postmenopausal osteoporosis with pathological fracture (Ankle and foot)	0.000	0.998	0.001
M80.06 Postmenopausal osteoporosis with pathological fracture (Lower leg)	0.000	0.998	0.001
M80.05 Postmenopausal osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.001
M80.04 Postmenopausal osteoporosis with pathological fracture (Hand)	0.000	0.998	0.001
M80.03 Postmenopausal osteoporosis with pathological fracture (Forearm)	0.000	0.998	0.001
M80.02 Postmenopausal osteoporosis with pathological fracture (Upper arm)	0.000	0.998	0.001
M80.01 Postmenopausal osteoporosis with pathological fracture (Shoulder region)	0.000	0.998	0.001
H49.8 Other paralytic strabismus	0.002	0.998	0.000
H49.4 Progressive external ophthalmoplegia	0.002	0.998	0.000
H49.3 Total (external) ophthalmoplegia	0.002	0.998	0.000
H51.9 Disorder of binocular movement, unspecified	0.001	0.998	0.000
H51.8 Other specified disorders of binocular movement	0.001	0.998	0.000
H51.1 Convergence insufficiency and excess	0.001	0.998	0.000
H51.0 Palsy of conjugate gaze	0.001	0.998	0.000
K55.2 Angiodysplasia of colon	0.002	0.998	0.000
K75 Other inflammatory liver diseases	0.000	0.998	0.002
M80.19 Postoophorectomy osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.001
M80.18 Postoophorectomy osteoporosis with pathological fracture (Other)	0.000	0.998	0.001
M80.17 Postoophorectomy osteoporosis with pathological fracture (Ankle and foot)	0.000	0.998	0.001
M80.16 Postoophorectomy osteoporosis with pathological fracture (Lower leg)	0.000	0.998	0.001
M80.15 Postoophorectomy osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.001
M80.14 Postoophorectomy osteoporosis with pathological fracture (Hand)	0.000	0.998	0.001
M80.13 Postoophorectomy osteoporosis with pathological fracture (Forearm)	0.000	0.998	0.001
M80.12 Postoophorectomy osteoporosis with pathological fracture (Upper arm)	0.000	0.998	0.001
M80.11 Postoophorectomy osteoporosis with pathological fracture (Shoulder region)	0.000	0.998	0.001
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.998	0.002
K65.9 Peritonitis, unspecified	0.002	0.998	0.000
M80.89 Other osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.001
M80.87 Other osteoporosis with pathological fracture (Ankle and foot)	0.000	0.998	0.001
M80.86 Other osteoporosis with pathological fracture (Lower leg)	0.000	0.998	0.001
M80.85 Other osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.001
M80.84 Other osteoporosis with pathological fracture (Hand)	0.000	0.998	0.001
M80.83 Other osteoporosis with pathological fracture (Forearm)	0.000	0.998	0.001
M80.82 Other osteoporosis with pathological fracture (Upper arm)	0.000	0.998	0.001
M80.80 Other osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.001
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.000	0.998	0.002
M80.52 Idiopathic osteoporosis with pathological fracture (Upper arm)	0.000	0.998	0.001
H02.1 Ectropion of eyelid	0.000	0.998	0.002
K91.9 Postprocedural disorder of digestive system, unspecified	0.001	0.998	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.998	0.002
M80.29 Osteoporosis of disuse with pathological fracture (Site unspecified)	0.000	0.998	0.001
M80.28 Osteoporosis of disuse with pathological fracture (Other)	0.000	0.998	0.001
M80.27 Osteoporosis of disuse with pathological fracture (Ankle and foot)	0.000	0.998	0.001
M80.26 Osteoporosis of disuse with pathological fracture (Lower leg)	0.000	0.998	0.001
M80.25 Osteoporosis of disuse with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.001
M80.24 Osteoporosis of disuse with pathological fracture (Hand)	0.000	0.998	0.001
M80.23 Osteoporosis of disuse with pathological fracture (Forearm)	0.000	0.998	0.001
M80.22 Osteoporosis of disuse with pathological fracture (Upper arm)	0.000	0.998	0.001
M80.21 Osteoporosis of disuse with pathological fracture (Shoulder region)	0.000	0.998	0.001
M80.20 Osteoporosis of disuse with pathological fracture (Multiple sites)	0.000	0.998	0.001
M80.39 Postsurgical malabsorption osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.001
M80.38 Postsurgical malabsorption osteoporosis with pathological fracture (Other)	0.000	0.998	0.001
M80.37 Postsurgical malabsorption osteoporosis with pathological fracture (Ankle and foot)	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations